Coagulation abnormalities in children with chronic liver disease and the association of these abnormalities with

Rubaiyat Alam1, Mst Arifa Main1, Khan Lamia Nahid1

  • 1Department of Pediatric Gastroenterology and Nutrition, Bangladesh Medical University, Dhaka 1000, Bangladesh.

Iliver
|December 4, 2025
PubMed

Insights

In pediatric chronic liver disease (CLD), international normalized ratio (INR) and albumin levels reliably predict disease severity. The albumin-bilirubin (ALBI) score offers a more consistent assessment of liver function than the Child-Pugh score for risk stratification.

Area of Science:

  • Pediatric Gastroenterology
  • Hepatology
  • Hematology

Background:

  • Chronic liver disease (CLD) in children presents complex challenges.
  • Coagulation abnormalities are common in CLD and can impact patient outcomes.
  • Understanding these abnormalities is crucial for effective disease management.

Purpose of the Study:

  • To evaluate the coagulation profile in pediatric patients with CLD.
  • To determine the relationship between coagulation status and CLD severity.
  • To identify reliable predictors of disease progression in pediatric CLD.

Main Methods:

  • Prospective study of 51 children with CLD, stratified by Child-Pugh class.
  • Analysis of laboratory parameters including complete blood count, prothrombin time, activated partial thromboplastin time (APTT), international normalized ratio (INR), fibrinogen, D-dimer, and albumin-bilirubin (ALBI) score.
  • Logistic regression used to identify independent predictors of Child-Pugh class.

Main Results:

  • Autoimmune hepatitis and Wilson's disease were the most frequent causes of CLD.
  • Clinical complications like ascites and encephalopathy were more prevalent in severe CLD (Child-Pugh C).
  • INR, APTT, and D-dimer levels increased with disease severity, while albumin decreased. INR and hypoalbuminemia were strong independent predictors.
  • The ALBI score correlated well with liver function markers and coagulation parameters.

Conclusions:

  • International normalized ratio (INR) and serum albumin are key indicators of disease severity in pediatric CLD.
  • The albumin-bilirubin (ALBI) score demonstrates superior reproducibility for assessing hepatic reserve compared to the Child-Pugh score.
  • The ALBI score is a valuable tool for risk stratification in children with CLD.
Abstract

Related Concept Videos

Disorders of Hemostasis01:24

Disorders of Hemostasis

Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
2.0K
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
203
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
169
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
862
Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
1.8K
Esophageal Varices-II: Clinical Features and Management01:28

Esophageal Varices-II: Clinical Features and Management

Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
343